Home / Adalimumab / Germany
DE ATC L04AB04 · updated 2 Nov 2026
Adalimumab shortage in Germany
Is there an Adalimumab shortage in Germany?
Yes. As of 2 Nov 2026, 2 Adalimumab products are reported short in Germany, the first since 1 Nov 2025. The company estimate for the return is 31 Dec 2026 (latest 20 Jan 2027). Main reason: other.
Also short in United States, Italy, Spain, Austria, Belgium, Czechia, Sweden. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Amsparity | Pfizer Europe MA EEIG | 1 Nov 2025 | 31 Dec 2026 | Other Sonstige |
| DE | Hukyndra | Stada | 31 Aug 2026 | 20 Jan 2027 | Manufacturing problem Probleme in der Herstellung |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.